UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display

Scientific reports, 2021-02, Vol.11 (1), p.3126-3126, Article 3126

2021

Volltextzugriff (PDF)

Association of the Influenza A Virus RNA-Dependent RNA Polymerase with Cellular RNA Polymerase II

Journal of Virology, 2005-05, Vol.79 (9), p.5812-5818

2005

Volltextzugriff (PDF)

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity

Frontiers in immunology, 2020-05, Vol.11, p.627-627

2020

Volltextzugriff (PDF)

Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses

Journal of virology, 2019-01, Vol.93 (2)

2019

Volltextzugriff (PDF)

Functional association between viral and cellular transcription during influenza virus infection

Reviews in medical virology, 2006-09, Vol.16 (5), p.329-345

2006

Volltextzugriff (PDF)

The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency

PloS one, 2014-08, Vol.9 (8), p.e103294-e103294

2014

Volltextzugriff (PDF)

Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection

Frontiers in immunology, 2023-08, Vol.14, p.1256094-1256094

2023

Volltextzugriff (PDF)

Role of Ran Binding Protein 5 in Nuclear Import and Assembly of the Influenza Virus RNA Polymerase Complex

Journal of Virology, 2006-12, Vol.80 (24), p.11911-11919

2006

Volltextzugriff (PDF)

The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein

PloS one, 2016-11, Vol.11 (11), p.e0166761-e0166761

2016

Volltextzugriff (PDF)

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

Frontiers in immunology, 2023-02, Vol.14, p.1129765-1129765

2023

Volltextzugriff (PDF)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines

Frontiers in immunology, 2018-10, Vol.9, p.2312-2312

2018

Volltextzugriff (PDF)

Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5

Journal of general virology, 2011-08, Vol.92 (Pt 8), p.1859-1869

2011

Volltextzugriff (PDF)

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

Frontiers in immunology, 2019-03, Vol.10, p.646-646

2019

Volltextzugriff (PDF)

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies

Vaccines (Basel), 2022-09, Vol.10 (9), p.1473

2022

Volltextzugriff (PDF)

Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study

mSphere, 2021-08, Vol.6 (4), p.e0056721-e0056721

2021

Volltextzugriff (PDF)

Improved Antigen Yield in Pandemic H1N1 (2009) Candidate Vaccine Viruses with Chimeric Hemagglutinin Molecules

Journal of Virology, 2011-06, Vol.85 (12), p.6086-6090

2011

Volltextzugriff (PDF)

An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs

Vaccine, 2012-01, Vol.30 (4), p.745-751

2012

Volltextzugriff (PDF)

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin

Antibodies (Basel), 2019-02, Vol.8 (1), p.14

2019

Volltextzugriff (PDF)

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study

Vaccine, 2018-11, Vol.36 (50), p.7641-7649

2018

Volltextzugriff (PDF)

Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model

Vaccine, 2021-08, Vol.39 (34), p.4903-4913

2021

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(65)
Buchkapitel
(1)

Sprache

Englisch
(65)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(53)
Humans
(38)
Influenza
(31)
Immunology
(29)
Animals
(28)
Vaccines
(26)
Virology
(26)
Viruses
(23)
Pandemics
(20)
Medicine, Research & Experimental
(19)
Research & Experimental Medicine
(19)
Influenza Vaccines
(14)
Laboratories
(14)
Influenza Vaccines - Immunology
(13)
Microbiology
(13)
Vaccine
(13)
Hemagglutinins
(12)
Influenza, Human - Prevention & Control
(11)
Antigens
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(18)
Journal Of Virology
(8)
Frontiers In Immunology
(7)
Influenza And Other Respiratory Viruses
(7)
Plos One
(7)
Journal Of General Virology
(4)
Biologicals
(2)
Experimental Cell Research
(2)
Vaccines
(2)
Antibodies
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display

WHO recommendations for the viruses used in the 2013–2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013

Association of the Influenza A Virus RNA-Dependent RNA Polymerase with Cellular RNA Polymerase II

Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity

Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses

Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study

Functional association between viral and cellular transcription during influenza virus infection

The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency

Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection

Role of Ran Binding Protein 5 in Nuclear Import and Assembly of the Influenza Virus RNA Polymerase Complex

The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines

Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies

Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study

Improved Antigen Yield in Pandemic H1N1 (2009) Candidate Vaccine Viruses with Chimeric Hemagglutinin Molecules

An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study

Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies

Suchergebnisse filtern